Nagler A - Search Results

1

Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.

Medalion B, Merin G, Aingorn H, Miao HQ, Nagler A, Elami A, Ishai-Michaeli R, Vlodavsky I. Medalion B, et al. Among authors: nagler a. Circulation. 1997 Apr 1;95(7):1853-62. doi: 10.1161/01.cir.95.7.1853. Circulation. 1997. PMID: 9107173

2

Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.

Nagler A, Miao HQ, Aingorn H, Pines M, Genina O, Vlodavsky I. Nagler A, et al. Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):194-202. doi: 10.1161/01.atv.17.1.194. Arterioscler Thromb Vasc Biol. 1997. PMID: 9012656

3

Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone.

Nagler A, Katz A, Aingorn H, Miao HQ, Condiotti R, Genina O, Pines M, Vlodavsky I. Nagler A, et al. Kidney Int. 1997 Dec;52(6):1561-9. doi: 10.1038/ki.1997.486. Kidney Int. 1997. PMID: 9407501 Free article.

4

Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.

Elkin M, Ariel I, Miao HQ, Nagler A, Pines M, de-Groot N, Hochberg A, Vlodavsky I. Elkin M, et al. Among authors: nagler a. Cancer Res. 1999 Aug 15;59(16):4111-8. Cancer Res. 1999. PMID: 10463616

5

Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.

Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, Dou HL, Pines M, Vlodavsky I. Elkin M, et al. Among authors: nagler a. FASEB J. 2000 Dec;14(15):2477-85. doi: 10.1096/fj.00-0292com. FASEB J. 2000. PMID: 11099465

6

Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.

Elkin M, Reich R, Nagler A, Aingorn E, Pines M, de-Groot N, Hochberg A, Vlodavsky I. Elkin M, et al. Among authors: nagler a. Clin Cancer Res. 1999 Aug;5(8):1982-8. Clin Cancer Res. 1999. PMID: 10473075

7

Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.

Nagler A, Ohana M, Shibolet O, Shapira MY, Alper R, Vlodavsky I, Pines M, Ilan Y. Nagler A, et al. Eur J Cancer. 2004 Jun;40(9):1397-403. doi: 10.1016/j.ejca.2003.11.036. Eur J Cancer. 2004. PMID: 15177499

8

Reduction in basic fibroblast growth factor mediated angiogenesis in vivo by linomide.

Nagler A, Feferman R, Shoshan S. Nagler A, et al. Connect Tissue Res. 1998;37(1-2):61-8. doi: 10.3109/03008209809028900. Connect Tissue Res. 1998. PMID: 9643647

9

Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.

Ostrovsky O, Korostishevsky M, Levite I, Leiba M, Galski H, Vlodavsky I, Nagler A. Ostrovsky O, et al. Among authors: nagler a. Leukemia. 2007 Nov;21(11):2296-303. doi: 10.1038/sj.leu.2404821. Epub 2007 Jul 5. Leukemia. 2007. PMID: 17611567

10

Heparanase enhances myeloma progression via CXCL10 downregulation.

Barash U, Zohar Y, Wildbaum G, Beider K, Nagler A, Karin N, Ilan N, Vlodavsky I. Barash U, et al. Among authors: nagler a. Leukemia. 2014 Nov;28(11):2178-87. doi: 10.1038/leu.2014.121. Epub 2014 Apr 4. Leukemia. 2014. PMID: 24699306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,458 results

Search Page

Filters